| Bioactivity | C6 NBD Sphingomyelin is a fluorescent short-chain analogue of Sphingomyelin (HY-113498). Chlamydia trachomatis acquires C6 NBD Sphingomyelin endogenously synthesizes from C6-NBD-ceramide and transportes to the chlamydial inclusion. C6 NBD Sphingomyelin can incorporate into the plasma membrane[1]. |
| Name | C6 NBD Sphingomyelin |
| CAS | 94885-04-8 |
| Formula | C35H61N6O9P |
| Molar Mass | 740.87 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Hackstadt T, et al. Chlamydia trachomatis interrupts an exocytic pathway to acquire endogenously synthesized sphingomyelin in transit from the Golgi apparatus to the plasma membrane. EMBO J. 1996 Mar 1;15(5):964-77. |
C6 NBD Sphingomyelin
CAS: 94885-04-8 F: C35H61N6O9P W: 740.87
C6 NBD Sphingomyelin is a fluorescent short-chain analogue of Sphingomyelin (HY-113498). Chlamydia trachomatis acquires
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.